Reports
Reports
Sale
The global femtech market size was valued at USD 28.7 billion in 2023, driven by the increasing focus of startups on developing improved healthcare for specific concerns among women across the globe. The market size is anticipated to grow at a CAGR of 12.4% during the forecast period of 2024-2032 to achieve a value of USD 87.9 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Femtech refers to the category of technologies, tools, and devices that are used to focus on the health of women. It includes software, products, tests, and services, ranging from consumer products and apps to diagnostics and telehealth. Femtech focuses on products that utilise technology in a manner to optimise the health of women, proactively and in case of health concerns.
An increase in the need for digital technology in the healthcare sector is driving the growth of the global femtech market. In the upcoming years, the rising popularity of wearable technology to track and monitor the well-being of patients is anticipated to increase the usage of femtech devices.
According to the femtech market analysis, growing concerns about women's health and wellness are projected to fuel the growth of the market for femtech products over the forecast period. As access to women's care in rural regions increases and the awareness regarding wellness in developing countries improves, the market is expected to witness significant demand.
Increasing measures undertaken by the governments of developing countries to boost the adoption of femtech products is one of the key femtech market trends. Femtech products available in the market address issues with pregnancy, reproduction, chronic illnesses, mental health, and general wellness, among others.
As per femtech market research, an increasing number of start-ups are concentrating on developing easy solutions for women's healthcare by comprehending their unique demands and difficulties, supporting market expansion. With more start-ups entering the market and raising awareness of femtech solutions, modernized and effective services will likely be available to more women all over the world.
Rising Application to Drive the Market Growth
Pregnancy and nursing care applications of femtech are expected to account for a substantial portion of the market as more women become pregnant at later ages and complications related to pregnancy and nursing increase. The rising demand for new and innovative products, including smart breast pumps is expected to drive the femtech market worth.
Also, it is anticipated that rising female awareness of contemporary technologies available that can aid in pregnancy and nursing and healthcare programs of various governments will further fuel the femtech market growth. The need for nursing care is anticipated to increase due to growing knowledge of the benefits of nursing and the rising availability of femtech solutions on digital platforms for easy diagnosis and monitoring. A surge in demand for higher-quality supplies and products used in pregnancy and nursing care is further boosting the femtech market value.
Increasing Fund Raisers
In Jan 2023, Oula, a New York-based maternity clinic focused on pregnancy and childbirth was founded on the belief that improving the experience will lead to better health outcomes and lower costs, raised USD 19.1 million in Series A funding.
The company plans to use the funds to improve its full-service maternity care including prenatal, delivery, and postpartum, as well as to increase the availability of group support and sonography services. This announcement has been at a crucial time, as maternal mortality rates in the United States are rising (especially for Black women), restrictions on reproductive rights are being imposed, and parents are facing a hard time, from a lack of accessible childcare to the absence of paid family leave.
Data in the factsheet curated by the World Health Organization showcase that an estimated 287,000 women died during and after pregnancy and childbirth in 2020. Almost 95% of all maternal deaths occurred in low and lower-middle-income countries in 2020, and most could have been prevented. This data showcases the urgency to bring treatments for women facing difficulties during and after pregnancy. This urgency is significant to realize as it is high time now and with all the advancements going around in the healthcare domain, it is important to make some exclusive changes and improvements in the domain of women's health to bolster the global femtech market growth in the forecast period.
Funding activities as mentioned play an important role in the development of the market as it will enable further advancements of technologies and systems to provide targeted and effective maternity healthcare.
Market Launches Boosting the Demand
In July 2023, award-winning gynecological health startup Daye announced the launch of the world’s first virtual Period Pain Clinic to help women and assigned female at birth (AFAB) individuals identify the root cause of their period pain and gain easy access to diagnostic information to help them manage their symptoms appropriately.
In collaboration with NHS GPs, gynecologists, and chronic pelvic pain specialists, Daye developed a groundbreaking new service called Period Pain Clinic (PPC) to help women comprehend and manage their period discomfort conveniently and affordably. This new service conducts a thorough assessment of a patient's symptoms and offers private consultations with a range of specialists, including sexual health nurses, gynecologists, pelvic pain and fertility specialists, nutritionists, dermatologists, breathwork coaches, acupuncturists, and more.
Professionally trained healthcare professionals are available in the facility to enable a faster diagnosis of the root cause of an individual’s period pain and conditions such as endometriosis, adenomyosis, polycystic ovarian syndrome (PCOS), fibroids, and other conditions associated with chronic pelvic pain. These professionals can also address other symptoms that are connected indirectly and are unmanaged, including infertility, hair loss, obesity, and severe acne.
Such exclusive moves to maintain dignity as well as provide convenience with comfort to patients suffering from severe menstrual discomfort and other related symptoms are anticipated to foster the market growth.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Product Type
Market Breakup by Application
Market by Distribution Channel
Market Breakup by End User
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America is dominating the market for femtech due to factors such as the rising prevalence of chronic conditions in women, the increase in infertility, and the growing awareness of femtech products and services among women. The market for femtech is expanding in the United States and other nations in the region as a result of the high incidences of cancer among women and the growing prevalence of lifestyle-related illnesses.
The expansion of the market in the North American region will also be aided by the increase in investments by the key players in the region, improved healthcare infrastructure, and rising knowledge of illnesses affecting women. With a sizable women workforce that continues to grow, more women are prioritizing their health and seeking technologies to support positive health, creating a sizable demand on the femtech market map.
In September 2023, a Chicago maternal health start-up Partum Health raised USD 3.1 million in seed round funding to improve maternal health outcomes in the United States. Research has shown that each year thousands of women face traumatic pregnancy, childbirth, and postpartum experiences that are largely preventable. Two factors that significantly contribute to the nation’s current maternal health crisis include the relative undersupply of maternity care providers and a lack of postpartum support. Partum Health aims to address and fulfil these crucial gaps of unmet needs by collaborating with obstetricians and midwives to provide patients with complementary and specialized care. Parum Health is also building a model that combines the convenience of mobile apps, chat, and on-demand care with hands-on support so that families can conveniently receive the care. The increasing focus of femtechs on providing convenient yet advanced healthcare is poised to play a crucial role in the femtech market growth during the forecast growth.
In May 2023, Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, announced certain commercial changes and plans to optimize its strategy and commercial structure to highly focus business activities on accelerating test adoption and revenue at significantly reduced operating costs.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product Type |
|
Breakup by Application |
|
Breakup by Distribution Channel |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Femtech Market Overview
3.1 Global Femtech Market Historical Value (2017-2023)
3.2 Global Femtech Market Forecast Value (2024-2032)
4 Global Femtech Market Landscape*
4.1 Global Femtech: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Femtech: Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Application
5 Global Femtech Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Femtech Market Segmentation (2017-2032 )
6.1 Global Femtech Market (2017-2032) by Product Type
6.1.1 Market Overview
6.1.2 Diagnostics
6.1.3 Monitoring
6.1.4 Therapeutic
6.1.5 Consumer Products
6.2 Global Femtech Market (2017-2032) by Application
6.2.1 Market Overview
6.2.2 General Health and Wellness
6.2.3 Maternity Care
6.2.4 Menstrual Health
6.2.5 Pelvic and Uterine Healthcare
6.2.6 Cancer and Chronic Disease
6.3 Global Femtech Market (2017-2032) by Distribution Channel
6.3.1 Market Overview
6.3.2 Retail
6.3.3 Online
6.4 Global Femtech Market (2017-2032) by End User
6.4.1 Market Overview
6.4.2 Direct-to-consumer
6.4.3 Hospitals
6.4.4 Surgical Centers
6.4.5 Fertility Clinics
6.4.6 Diagnostics Centers
6.5 Global Femtech Market (2017-2032) by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Femtech Market (2017-2032)
7.1 North America Femtech Market (2017-2032) by Product Type
7.1.1 Market Overview
7.1.2 Diagnostics
7.1.3 Monitoring
7.1.4 Therapeutic
7.1.5 Consumer Products
7.2 North America Femtech Market (2017-2032) by Application
7.2.1 Market Overview
7.2.2 General Health and Wellness
7.2.3 Maternity Care
7.2.4 Menstrual Health
7.2.5 Pelvic and Uterine Healthcare
7.2.6 Cancer and Chronic Disease
7.3 North America Femtech Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Femtech Market (2017-2032)
8.1 Europe Femtech Market (2017-2032) by Product Type
8.1.1 Market Overview
8.1.2 Diagnostics
8.1.3 Monitoring
8.1.4 Therapeutic
8.1.5 Consumer Products
8.2 Europe Femtech Market (2017-2032) by Application
8.2.1 Market Overview
8.2.2 General Health and Wellness
8.2.3 Maternity Care
8.2.4 Menstrual Health
8.2.5 Pelvic and Uterine Healthcare
8.2.6 Cancer and Chronic Disease
8.3 Europe Femtech Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Femtech Market (2017-2032)
9.1 Asia Pacific Femtech Market (2017-2032) by Product Type
9.1.1 Market Overview
9.1.2 Diagnostics
9.1.3 Monitoring
9.1.4 Therapeutic
9.1.5 Consumer Products
9.2 Asia Pacific Femtech Market (2017-2032) by Application
9.2.1 Market Overview
9.2.2 General Health and Wellness
9.2.3 Maternity Care
9.2.4 Menstrual Health
9.2.5 Pelvic and Uterine Healthcare
9.2.6 Cancer and Chronic Disease
9.3 Asia Pacific Femtech Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 ASEAN
9.3.5 Others
10 Latin America Femtech Market (2017-2032)
10.1 Latin America Femtech Market (2017-2032) by Product Type
10.1.1 Market Overview
10.1.2 Diagnostics
10.1.3 Monitoring
10.1.4 Therapeutic
10.1.5 Consumer Products
10.2 Latin America Femtech Market (2017-2032) by Application
10.2.1 Market Overview
10.2.2 General Health and Wellness
10.2.3 Maternity Care
10.2.4 Menstrual Health
10.2.5 Pelvic and Uterine Healthcare
10.2.6 Cancer and Chronic Disease
10.3 Latin America Femtech Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Femtech Market (2017-2032)
11.1 Middle East and Africa Femtech Market (2017-2032) by Product Type
11.1.1 Market Overview
11.1.2 Diagnostics
11.1.3 Monitoring
11.1.4 Therapeutic
11.1.5 Consumer Products
11.2 Middle East and Africa Femtech Market (2017-2032) by Application
11.2.1 Market Overview
11.2.2 General Health and Wellness
11.2.3 Maternity Care
11.2.4 Menstrual Health
11.2.5 Pelvic and Uterine Healthcare
11.2.6 Cancer and Chronic Disease
11.3 Middle East and Africa Femtech Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication Year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Flo Health Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Clue Blowink GmbH
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Glow Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Natural Cycles USA Corp
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Withings
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Fitbit Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Chiaro Technology Ltd.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Joylux Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Coroflo Ltd.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 HeraMED
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Sera Prognostics
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 iSono Health, Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Maven Clinic Co.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Ovia Health
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Willow Innovations, Inc.
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
List not exhaustive
18 Global Femtech Market – Distribution Model (Additional Insights)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
The market attained a value of about USD 28.7 billion in 2023, driven by the increasing health issues in women.
The market is anticipated to grow at a CAGR of 12.4% during the forecast period of 2024-2032 and is likely to reach a market value of USD 87.9 billion by 2032.
Factors such as increasing digitization in the healthcare sector, rising popularity of wearable technology, increasing awareness about women health, increasing government initiatives to address crucial gaps of unmet medical needs in women healthcare and fundraising activities are aiding the market demand.
The market growth is influenced by trends such as increasing strategic launches of healthcare services and clinics by market players and strategic changes in existing settings.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
Types of products include diagnostics, monitoring, therapeutic, and consumer products.
Femtech finds wide applications in general health and wellness, maternity care, menstrual health, pelvic and uterine healthcare, cancer, and chronic disease.
Distribution channels include retail and online.
End users in the market include direct-to-consumer, hospitals, surgical centers, fertility clinics, and diagnostics centers.
Key players involved in the market are Flo Health Inc., Clue Blowink GmbH, Glow Inc., Natural Cycles USA Corp, Withings, Fitbit Inc., Chiaro Technology Ltd., Joylux Inc., Coroflo Ltd., HeraMED, Sera Prognostics, iSono Health, Inc., Maven Clinic Co., Willow Innovations, Inc., and Ovia Health.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.